Anti-HLA-DR antibody [L243] (ab136320)
Key features and details
- Mouse monoclonal [L243] to HLA-DR
- Suitable for: Flow Cyt
- Reacts with: Human
- Isotype: IgG2a
Overview
-
Product name
Anti-HLA-DR antibody [L243]
See all HLA-DR primary antibodies -
Description
Mouse monoclonal [L243] to HLA-DR -
Host species
Mouse -
Specificity
ab136320 recognizes specifically HLA-DR molecules both peptide-loaded and empty. -
Tested applications
Suitable for: Flow Cytmore details -
Species reactivity
Reacts with: Human -
Immunogen
Tissue, cells or virus corresponding to Human HLA-DR. Human B lymphocytes.
-
Positive control
- Flow Cytometry: Human peripheral blood cells.
-
General notes
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. -
Storage buffer
pH: 7.40
Preservative: 0.1% Sodium azide
Constituent: PBS -
Concentration information loading...
-
Purity
Protein A purified -
Purification notes
Purified from cell culture supernatant by protein A affinity chromatography. Purity: > 95% (by SDS-PAGE). -
Clonality
Monoclonal -
Clone number
L243 -
Isotype
IgG2a -
Light chain type
kappa -
Research areas
Images
-
Flow Cytometry analysis of human peripheral blood cells labeling HLA DR with ab136320, followed by a Goat anti-mouse-APC secondary.
-
Human peripheral blood lymphocytes stained with ab136320 (red line). Human whole blood was processed using a modified protocol based on Chow et al, 2005 (PMID: 16080188).
In brief, human whole blood was fixed in 4% formaldehyde (methanol-free) for 10 minutes at 22°C. Red blood cells were then lyzed by the addition of Triton X-100 (final concentration - 0.1%) for 15 minutes at 37°C. For experimentation, cells were treated with 50% methanol (-20°C) for 15 minutes at 4°C. Cells were then incubated with the antibody (ab136320, 0.1μg/1x106 cells) for 30 minutes at 4°C. The secondary antibody used was Alexa Fluor® 488 goat anti-mouse IgG (H&L) (ab150113) at 1/2000 dilution for 30 minutes at 4°C. Isotype control antibody (black line) was mouse IgG2a [ICIGG2A] (ab91361, 0.1μg/1x106cells) used under the same conditions. Unlabeled sample (blue line) was also used as a control. Acquisition of >30,000 total events were collected using a solid-state 25mW red diode laser (635nm) and 675/30 bandpass filter. Gating strategy - peripheral blood lymphocytes.